Intellia Therapeutics Inc (NTLA) is destined for greater heights as its last quarter sales were 11,990 K
Intellia Therapeutics Inc (NASDAQ: NTLA) on Tuesday, plunged -2.12% from the previous trading day, before settling in for the closing price of $26.83. Within the